RankingsPricing
  1. JP-listed companies
  2. COSMO BIO COMPANY, LIMITED
  3. Financials
  4. Marketable securities, non-current

COSMO BIO COMPANY, LIMITED【JP:3386】

Market cap
¥7.9B
P/E ratio
17.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Dec 31, 20243,288+19.04%
Dec 31, 20232,762+29.31%
Dec 31, 20222,136+25.65%
Dec 31, 20211,700-6.44%
Dec 31, 20201,817+0.33%
Dec 31, 20191,811+6.91%
Dec 31, 20181,694-4.67%
Dec 31, 20171,777+13.33%
Dec 31, 20161,568-13.89%
Dec 31, 20151,821-22.25%
Dec 31, 20142,342

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)